Cleared Traditional

K051395 - LANGSTON DUAL LUMEN PRESSURE MONITORING...

K051395 is the FDA 510(k) clearance for LANGSTON DUAL LUMEN PRESSURE MONITORING... by Vascular Solutions, Inc.. It is a Class 2 Cardiovascular device (product code DQO) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2005
Decision
28d
Days
Class 2
Risk

K051395 is an FDA 510(k) clearance for the LANGSTON DUAL LUMEN PRESSURE MONITORING CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Vascular Solutions, Inc. (Minneapolis, US). The FDA issued a Cleared decision on June 24, 2005 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vascular Solutions, Inc. devices

Submission Details

510(k) Number K051395 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 27, 2005
Decision Date June 24, 2005
Days to Decision 28 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 269
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K051395.
HOSPIRA CATH LAB CONVENIENCE KITS
K052865 · Icu Medical, Inc. · Dec 2005
ASAHI ANGIOGRAPHIC CATHETER
K051561 · Asahi Intecc Co., Ltd. · Nov 2005
IMAGER II ANGIOGRAPHIC CATHETER
K050863 · Boston Scientific Corp · Sep 2005
MEDRAD VANGUARD DX ANGIOGRAPHIC CATHETER
K050371 · Medrad, Inc. · Jun 2005
ATLANTIS PV
K050684 · Boston Scientific Corp · May 2005
LANGSTON DUAL LUMEN PRESSURE MONITORING CATHETER
K050168 · Vascular Solutions, Inc. · May 2005